The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

about

The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

Item

http://www.wikidata.org/entity/Q40439101

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The cross-sectional associatio ...... evels in postmenopausal women.

@en

type

Item

label

The cross-sectional associatio ...... evels in postmenopausal women.

@en

prefLabel

The cross-sectional associatio ...... evels in postmenopausal women.

@en

P1476

The cross-sectional associatio ...... evels in postmenopausal women.

@en

P2093

Andrea Z LaCroix

http://www.w3.org/2001/XMLSchema#string

Andrew M Kaunitz

http://www.w3.org/2001/XMLSchema#string

Barbara McKnight

http://www.w3.org/2001/XMLSchema#string

Jacques E Rossouw

http://www.w3.org/2001/XMLSchema#string

Jan Rosing

http://www.w3.org/2001/XMLSchema#string

Karen C Johnson

http://www.w3.org/2001/XMLSchema#string

Laura B Harrington

http://www.w3.org/2001/XMLSchema#string

Lisa W Martin

http://www.w3.org/2001/XMLSchema#string

Marc Blondon

http://www.w3.org/2001/XMLSchema#string

Nicholas L Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

Multiple imputation by chained equations: what is it and how does it work?

The Women's Health Initiative recruitment methods and results.

National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms.

Vasomotor symptoms and coronary artery calcium in postmenopausal women.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation.

P304

360-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GME.0000000000000777

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27922933

http://www.w3.org/2001/XMLSchema#string

P932

5365368

http://www.w3.org/2001/XMLSchema#string